PATENT CLAIM ANALYSIS

Application Number: 15866303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 15):
The co-crystal of  claim 13 , wherein the molecular ratio between the N-methylglycine and fumaric acid in the co-crystal is 2:1, and wherein the co-crystal has a powder X-ray diffraction pattern at a 2\u03b8 angle with peaks (\u00b0) of: 7.66, 9.89, 12.06, 12.78, 14.00, 15.52, 16.40, 16.58, 17.14, 17.49, 18.42, 19.74, 20.12, 20.75, 22.22, 22.46, 22.93, 23.16, 23.93, 24.29, 24.52, 24.66, 25.32, 25.66, 26.18, 26.98, 27.86, 29.00, 31.06, 31.41, 31.62, 32.96, 33.28, 33.46, 34.45, 34.70, 35.55, and 37.01.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15430750', '15188545', '14358606', '14799281', '14777018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7820068610453625
- 35 USC 102 Novelty (BERT): 0.561358790900723
- Combined Prediction Score: 0.7599420540308987
- Mean Citation Score: 320.9926200000001
- Max Citation Score: 471.8377
- Similarity Product: 317.8614099130511

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test